[Form 4] MDWerks, Inc. Insider Trading Activity

Rhea-AI Filing Summary

MDWerks, Inc. director and reporting person Timothy Brocopp reported a new grant of company common stock. On 11/13/2025, he acquired 65,325 shares of MDWerks common stock at a stated price of $0.153 per share. After this transaction, he beneficially owned 2,990,677 shares of MDWerks common stock in direct ownership.

The filing explains that this grant was issued on a quarterly basis under an Employment Agreement between the reporting person and MDWerks dated November 18, 2024. The grant was approved by MDWerks’ board of directors and was made in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, which governs certain insider equity awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brocopp Timothy

(Last) (First) (Middle)

411 WALNUT STREET, SUITE 20125

(Street)

GREEN COVE SPRINGS, FL 32043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MDWerks, Inc. [ MDWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A		65,325(1)	A	$0.153	2,990,677	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on November 18, 2024. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.

	/s/ Timothy Brocopp	12/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MDWerks (MDWK) disclose in this Form 4?

The Form 4 reports that a director of MDWerks, Inc. acquired 65,325 shares of MDWerks common stock on 11/13/2025 at a stated price of $0.153 per share.

Who is the reporting person in the MDWerks (MDWK) Form 4 filing?

The reporting person is Timothy Brocopp, who is identified in the filing as a Director of MDWerks, Inc.

How many MDWerks (MDWK) shares does the insider own after this transaction?

Following the reported grant, the insider beneficially owned 2,990,677 shares of MDWerks common stock, held in direct ownership.

What was the basis for the MDWerks (MDWK) stock grant to the director?

The filing states that the 65,325-share grant was issued on a quarterly basis under an Employment Agreement between the reporting person and MDWerks dated November 18, 2024.

Was the MDWerks (MDWK) equity grant approved under Rule 16b-3?

Yes. The filing notes that the grant was approved by MDWerks’ board of directors and issued in accordance with Rule 16b-3 under the Securities Exchange Act of 1934.

Is the MDWerks (MDWK) Form 4 filed by one or multiple reporting persons?

The form is indicated as being filed by one reporting person, not by a group.